Association of Implementation of a Universal Testing and Treatment Intervention With HIV Diagnosis, Receipt of Antiretroviral Therapy, and Viral Suppression in East Africa
Author(s) -
Maya Petersen,
Laura B. Balzer,
Dalsone Kwarsiima,
Norton Sang,
Gabriel Chamie,
James Ayieko,
Jane Kabami,
Asiphas Owaraganise,
Teri Liegler,
Florence Mwangwa,
Kevin Kadede,
Vivek Jain,
Albert Plenty,
Lillian B. Brown,
Geoff Lavoy,
Joshua Schwab,
Douglas Black,
Mark van der Laan,
Elizabeth A. Bukusi,
Craig R. Cohen,
Tamara D. Clark,
Edwin D. Charlebois,
Moses R. Kamya,
Diane V. Havlir
Publication year - 2017
Publication title -
jama
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.688
H-Index - 680
eISSN - 1538-3598
pISSN - 0098-7484
DOI - 10.1001/jama.2017.5705
Subject(s) - medicine , serostatus , viral load , population , observational study , immunology , pediatrics , human immunodeficiency virus (hiv) , environmental health
Antiretroviral treatment (ART) is now recommended for all HIV-positive persons. UNAIDS has set global targets to diagnose 90% of HIV-positive individuals, treat 90% of diagnosed individuals with ART, and suppress viral replication among 90% of treated individuals, for a population-level target of 73% of all HIV-positive persons with HIV viral suppression.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom